Bangkok is strengthening its efforts to combat HIV and sexually transmitted infections (STIs) through a new collaborative ...

Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV.

Thailand’s HIV crisis is back after health chiefs revealed more than half a million people in the kingdom are living with the ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Although world is not on track to end AIDS by 2030 but it is no less than a miracle when we take into account the scientific ...

Borey and Sophia are among the first clients in Cambodia to begin long-acting injectable Cabotegravir (CAB-LA), a PrEP ...

Three years since Thailand became the first country in Asia to decriminalize cannabis, the government this week imposed new ...

Tourism operators show overwhelming interest in new government initiative offering up to 3,000 Baht per night in hotel ...

Yeztugo is the first and only twice-yearly PrEP option to prevent HIV. It offers a more convenient option than a daily pill. But it may face insurance access challenges.

Gilead’s recently approved drug for HIV prevention, Yeztugo (lenacapavir), has the potential to transform the pre-exposure prophylaxis (PrEP) sector in the US, according to market analysts. The US ...

Cambodia is the first country in the Asia-Pacific region to implement CAB-PrEP as part of a comprehensive HIV prevention strategy that offers multiple options for protection.